• Author: Michael D. George
Clear all

Agreement of administrative pharmacy dispensing with self-reported use of oral prednisone in U.S. Veterans with rheumatoid arthritis

Abstract: Objective: Administrative claims are used to evaluate oral glucocorticoid use in rheumatoid arthritis (RA), despite limited evidence to support accuracy. We aimed to …

Advanced therapies in US Veterans with rheumatoid arthritis-associated interstitial lung disease: A retrospective, active-comparator, new-user, cohort study

Abstract: Background: Uncertainty exists regarding patient outcomes when using TNF inhibitors versus other biological and targeted synthetic disease-modifying antirheumatic drugs …

Escalation to biologics after methotrexate among US Veterans with rheumatoid arthritis grouped by rural versus urban areas

Abstract: Objective: Racial and ethnic disparities in rheumatoid arthritis (RA) outcomes are well recognized. However, whether disparities in RA treatment selection and outcomes …

Changes in patterns of use of advanced therapies following emerging data about adverse events in patients with rheumatoid arthritis from the Veterans Affairs health system

Abstract: Objective: To determine whether prescribing practices for Janus kinase inhibitors (JAKi), tumor necrosis factor inhibitors (TNFi), and non-TNFi biologic agents changed …